Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stephanie Federico

Showing results (31-40 of 57) with videos related to

Pageof 6
Sort By:
Bioorganic & Medicinal Chemistry Letters|April 23, 2011
Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A3 adenosine receptor antagonistsSiew Lee Cheong, Stephanie Federico, Gopalakrishnan Venkatesan, et al.
Journal of Medicinal Chemistry|June 28, 2014
Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship studyStephanie Federico, Antonella Ciancetta, Nicola Porta, et al.
Medchemcomm|August 9, 2019
Pyrazolo[4,3-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidines to develop functionalized ligands to target adenosine receptors: fluorescent ligands as an exampleStephanie Federico, Enrico Margiotta, Silvia Paoletta, et al.
In Silico Pharmacology|January 9, 2018
Impact of protein-ligand solvation and desolvation on transition state thermodynamic properties of adenosine A<sub>2A</sub> ligand binding kineticsGiuseppe Deganutti, Andrei Zhukov, Francesca Deflorian, et al.
European Journal of Medicinal Chemistry|November 6, 2013
8-(2-Furyl)adenine derivatives as A₂A adenosine receptor ligandsDiego Dal Ben, Michela Buccioni, Catia Lambertucci, et al.
Chemmedchem|April 28, 2023
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine ReceptorsTeresa Gianferrara, Matteo Pavan, Davide Bassani, et al.
Chemmedchem|July 25, 2020
Targeting G Protein-Coupled Receptors with Magnetic Carbon Nanotubes: The Case of the A<sub>3</sub> Adenosine ReceptorFlorent Pineux, Stephanie Federico, Karl-Norbert Klotz, et al.
Molecular Pharmaceutics|February 2, 2012
A novel conjugated agent between dopamine and an A2A adenosine receptor antagonist as a potential anti-Parkinson multitarget approachAlessandro Dalpiaz, Barbara Cacciari, Chiara Beatrice Vicentini, et al.
Chemmedchem|February 8, 2024
Gaucher Disease: A Glance from a Medicinal Chemistry PerspectiveFilippo Prencipe, Chiara Barzan, Chiara Savian, et al.
Biochemical Pharmacology|March 10, 2012
Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometryEszter Kozma, T Santhosh Kumar, Stephanie Federico, et al.
Pageof 6

Showing results (31-40 of 57) with videos related to

Sort By:
Pageof 6
Bioorganic & Medicinal Chemistry Letters|April 23, 2011
Pharmacophore elucidation for a new series of 2-aryl-pyrazolo-triazolo-pyrimidines as potent human A3 adenosine receptor antagonistsSiew Lee Cheong, Stephanie Federico, Gopalakrishnan Venkatesan, et al.
Journal of Medicinal Chemistry|June 28, 2014
Scaffold decoration at positions 5 and 8 of 1,2,4-triazolo[1,5-c]pyrimidines to explore the antagonist profiling on adenosine receptors: a preliminary structure-activity relationship studyStephanie Federico, Antonella Ciancetta, Nicola Porta, et al.
Medchemcomm|August 9, 2019
Pyrazolo[4,3-<i>e</i>][1,2,4]triazolo[1,5-<i>c</i>]pyrimidines to develop functionalized ligands to target adenosine receptors: fluorescent ligands as an exampleStephanie Federico, Enrico Margiotta, Silvia Paoletta, et al.
In Silico Pharmacology|January 9, 2018
Impact of protein-ligand solvation and desolvation on transition state thermodynamic properties of adenosine A<sub>2A</sub> ligand binding kineticsGiuseppe Deganutti, Andrei Zhukov, Francesca Deflorian, et al.
European Journal of Medicinal Chemistry|November 6, 2013
8-(2-Furyl)adenine derivatives as A₂A adenosine receptor ligandsDiego Dal Ben, Michela Buccioni, Catia Lambertucci, et al.
Chemmedchem|April 28, 2023
Are Two Riboses Better Than One? The Case of the Recognition and Activation of Adenosine ReceptorsTeresa Gianferrara, Matteo Pavan, Davide Bassani, et al.
Chemmedchem|July 25, 2020
Targeting G Protein-Coupled Receptors with Magnetic Carbon Nanotubes: The Case of the A<sub>3</sub> Adenosine ReceptorFlorent Pineux, Stephanie Federico, Karl-Norbert Klotz, et al.
Molecular Pharmaceutics|February 2, 2012
A novel conjugated agent between dopamine and an A2A adenosine receptor antagonist as a potential anti-Parkinson multitarget approachAlessandro Dalpiaz, Barbara Cacciari, Chiara Beatrice Vicentini, et al.
Chemmedchem|February 8, 2024
Gaucher Disease: A Glance from a Medicinal Chemistry PerspectiveFilippo Prencipe, Chiara Barzan, Chiara Savian, et al.
Biochemical Pharmacology|March 10, 2012
Novel fluorescent antagonist as a molecular probe in A(3) adenosine receptor binding assays using flow cytometryEszter Kozma, T Santhosh Kumar, Stephanie Federico, et al.
Pageof 6